New results on the safety of laparoscopic sleeve gastrectomy bariatric procedure for type 2 diabetes patients.
Bariatric surgery
Clavien-Dindo classification
Complications
Fasting plasma glucose
Hemoglobin A1c
Laparoscopic sleeve gastrectomy
Morbidity
Type 2 diabetes
Journal
World journal of diabetes
ISSN: 1948-9358
Titre abrégé: World J Diabetes
Pays: United States
ID NLM: 101547524
Informations de publication
Date de publication:
15 Feb 2019
15 Feb 2019
Historique:
received:
06
11
2018
revised:
08
01
2019
accepted:
22
01
2019
entrez:
22
2
2019
pubmed:
23
2
2019
medline:
23
2
2019
Statut:
ppublish
Résumé
It has been established that bariatric surgery, including laparoscopic sleeve gastrectomy (LSG), has a positive impact on type 2 diabetes mellitus (T2DM). However, less frequently T2DM is reported as a risk factor for complications with this type of surgery. To evaluate the safety of LSG in T2DM. A retrospective cohort study was conducted over patients admitted for LSG from January 2008 to May 2015. Data was collected through digitized records. Any deviation from normal postoperative care within the first 60 d was defined as an early complication, and further categorized into mild or severe. Nine hundred eighty-four patients underwent LSG, among these 143 (14.5%) were diagnosed with T2DM. There were 19 complications in the T2DM group (13.3%) compared to 59 cases in the non-T2DM (7.0%). Out of 19 complications in the T2DM group, 12 were mild (8.4%) and 7 were severe (4.9%). Compared to the non-T2DM group, patients had a higher risk for mild complications (Odds-ratio 2.316, CI: 1.163-4.611, Our data suggest that LSG is relatively safe for patients with T2DM. Whether pre-operative control of hemoglobin A1c level will lower the complications rate has to be prospectively studied.
Sections du résumé
BACKGROUND
BACKGROUND
It has been established that bariatric surgery, including laparoscopic sleeve gastrectomy (LSG), has a positive impact on type 2 diabetes mellitus (T2DM). However, less frequently T2DM is reported as a risk factor for complications with this type of surgery.
AIM
OBJECTIVE
To evaluate the safety of LSG in T2DM.
METHODS
METHODS
A retrospective cohort study was conducted over patients admitted for LSG from January 2008 to May 2015. Data was collected through digitized records. Any deviation from normal postoperative care within the first 60 d was defined as an early complication, and further categorized into mild or severe.
RESULTS
RESULTS
Nine hundred eighty-four patients underwent LSG, among these 143 (14.5%) were diagnosed with T2DM. There were 19 complications in the T2DM group (13.3%) compared to 59 cases in the non-T2DM (7.0%). Out of 19 complications in the T2DM group, 12 were mild (8.4%) and 7 were severe (4.9%). Compared to the non-T2DM group, patients had a higher risk for mild complications (Odds-ratio 2.316, CI: 1.163-4.611,
CONCLUSION
CONCLUSIONS
Our data suggest that LSG is relatively safe for patients with T2DM. Whether pre-operative control of hemoglobin A1c level will lower the complications rate has to be prospectively studied.
Identifiants
pubmed: 30788045
doi: 10.4239/wjd.v10.i2.78
pmc: PMC6379729
doi:
Types de publication
Journal Article
Langues
eng
Pagination
78-86Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors have no competing interests to declare.
Références
Diabetologia. 2004 Jun;47(6):1047-54
pubmed: 15164170
Diabet Med. 2006 Jun;23(6):594-608
pubmed: 16759300
Curr Heart Fail Rep. 2006 Dec;3(4):164-9
pubmed: 17129509
Arch Surg. 2007 Oct;142(10):969-75; discussion 976
pubmed: 17938311
Diabetes Care. 2009 Jan;32 Suppl 1:S13-61
pubmed: 19118286
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
N Engl J Med. 2009 Jul 30;361(5):445-54
pubmed: 19641201
Ann Surg. 2010 Mar;251(3):399-405
pubmed: 19934752
JAMA. 2010 Jul 28;304(4):435-42
pubmed: 20664044
Arch Surg. 2010 Sep;145(9):858-64
pubmed: 20855756
Obes Surg. 2011 May;21(5):655-62
pubmed: 21161606
Ann Surg. 2011 Oct;254(4):633-40
pubmed: 21897200
Lancet. 2012 Jun 16;379(9833):2300-11
pubmed: 22683132
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):749-52
pubmed: 22884300
Surg Obes Relat Dis. 2012 Nov-Dec;8(6):671-7
pubmed: 23058451
Diabetes Care. 2014;37(3):611-6
pubmed: 24170760
Am J Orthop (Belle Mead NJ). 2013 Oct;42(10):E88-90
pubmed: 24278910
J Orthop Sci. 2014 Mar;19(2):223-228
pubmed: 24368606
Diabetes Res Clin Pract. 2014 Aug;105(2):141-50
pubmed: 24798950
Dig Surg. 2014;31(1):40-7
pubmed: 24819496
Surg Endosc. 2014 Dec;28(12):3302-9
pubmed: 25115863
Bone Joint J. 2014 Dec;96-B(12):1637-43
pubmed: 25452366
Surg Obes Relat Dis. 2015 Mar-Apr;11(2):399-405
pubmed: 25604834
Surg Infect (Larchmt). 2015 Jun;16(3):281-6
pubmed: 25830815
Acta Diabetol. 2015 Dec;52(6):1007-16
pubmed: 25850539
Obes Surg. 2015 Dec;25(12):2290-301
pubmed: 25937046
Acta Orthop. 2015;86(5):586-93
pubmed: 25953426
Am J Kidney Dis. 2015 Oct;66(4):602-12
pubmed: 25975964
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):758-64
pubmed: 26117166
Surg Endosc. 2016 Jun;30(6):2342-50
pubmed: 26307598
J Diabetes Complications. 2015 Nov-Dec;29(8):1177-82
pubmed: 26355027
Pneumonol Alergol Pol. 2015;83(5):401-8
pubmed: 26379004
JAMA Surg. 2015 Dec;150(12):1126-33
pubmed: 26422580
Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1199-200
pubmed: 26476493
Surgery. 2016 Apr;159(4):1113-20
pubmed: 26506567
Am J Surg. 2016 Jul;212(1):76-80
pubmed: 27133197
Obes Surg. 2016 Dec;26(12):2829-2836
pubmed: 27193106
Surg Endosc. 2017 Feb;31(2):907-911
pubmed: 27501726
Oncotarget. 2016 Dec 27;7(52):87511-87522
pubmed: 27626180
Ann Surg. 2018 Jan;267(1):122-131
pubmed: 27849660
Diabetes Care. 2017 Jan;40(Suppl 1):S57-S63
pubmed: 27979894
JAMA Surg. 2017 Nov 1;152(11):1031-1038
pubmed: 28746706
Dent Traumatol. 2017 Dec;33(6):438-443
pubmed: 28888078
J Trauma Acute Care Surg. 2018 Jan;84(1):112-117
pubmed: 29040204
Diabet Med. 1997 Jan;14(1):29-34
pubmed: 9017350